Community oncologists cited prior authorization as a care barrier, even as AI adoption doubled in 2026, according to the Oncology Care Index.
|Articles|May 25, 2012
Medical Devices in Hospitals to Go Wireless
Advertisement
Hospitals are getting ready to cut the cord.
In place of knots of wires stuck to patients to monitor their blood pressure, heart rate, oxygen level and body temperature, doctors and the companies that supply them hope to use Band-Aid-like sensors to accomplish the same task wirelessly.
The Federal Communications Commission is expected to vote Thursday to open up spectrum for wireless medical devices, raising the possibility of easier hospital-patient monitoring, fewer tubes in emergency rooms, and more remote monitoring at home.
Read the full story:
Source: The Wall Street Journal
Advertisement
Related to this article
Payers say NCCN guideline concordance sets a baseline for cancer coverage, but cost and formulary variation may still limit access.
Portuguese patch testing finds many chronic hand eczema cases link to allergic contact dermatitis—especially occupational exposures like methylisothiazolinone, HEMA acrylates, thiuram mix, nickel.
Two posters report 3.9% first-year GLP-1 discontinuation and a 5-day median time to first fill under pharmacist-led care.
CDC's Jane Henley, MSPH, explains what's behind falling lung cancer deaths and why 4 in 5 eligible adults still aren't getting screened.
The regulatory decisions reflect how advances in biomarkers and molecular medicine are reshaping both diagnosis and treatment.
As peptides go mainstream, the FDA's shifting rules and a fractured state patchwork leave patients navigating a largely unregulated gray market.
A large propensity-matched study linked outpatient melatonin use to a small reduction in REM sleep in children evaluated for polysomnography.
Advertisement
Advertisement
Trending on AJMC
1
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
2
NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma
3
Switching to Subcutaneous Ocrelizumab for MS Could Free 883 Chair Hours in a Year
4
Why 4 in 5 Eligible Adults Miss Lung Cancer Screening
5